Alliance Pharma PLC received a notification from Van Lanschot Kempen Investment Management NV regarding a change in their shareholding. The notification, dated 11th June 2024, indicates that Van Lanschot Kempen Investment Management NV now holds 7.763070% of the voting rights in Alliance Pharma PLC, representing a decrease from their previous position of 8.911100%. This change occurred on 7th June 2024.

The details provided in the notification show that Van Lanschot Kempen Investment Management NV holds a total of 41,951,695 voting rights in Alliance Pharma PLC, with 4,594 direct voting rights and 41,947,101 indirect voting rights. This represents 0.000840% and 7.762230% of direct and indirect voting rights, respectively.

The notification also confirms that Van Lanschot Kempen Investment Management NV does not control any other undertaking holding an interest in Alliance Pharma PLC, nor is it controlled by any other entity. Additionally, there is no information provided regarding proxy voting or any additional details related to this notification.

This notification provides insight into the changes in major shareholding within Alliance Pharma PLC and offers transparency regarding the ownership and voting rights within the company.